Case Study

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud

Discover how Certara's Phoenix Hosted streamlined data compliance and management for a biotech company, enhancing…

CertaraMay 31, 2024

Blog

Phoenix UGM 2024: A day of innovation and collaboration

The Phoenix UGM featured industry expert insights, peer networking, and glimpses into the latest PK/PD…

CertaraMay 31, 2024

Publication

Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults

Explore how nifedipine CR formulations are bioequivalent; food reduces exposure modestly, analysed using Phoenix WinNonlin.

CertaraMarch 13, 2024

Publication

Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors

Discover how PopPK modelling supports dose‑adjustment considerations for ORIN1001 based on bilirubin and lean body…

CertaraMarch 4, 2024

On-Demand Webinar

What is new in Phoenix 8.5?

Discover the latest advancements and enhancements in Phoenix version 8.5. Watch the webinar to learn…

CertaraFebruary 26, 2024

Publication

Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu

See how DRG‑based PK‑TD modelling predicts neuropathy severity and supports safer oxaliplatin dosing strategies using…

CertaraFebruary 1, 2024

Publication

Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis

Learn how both regimens achieve PK/PD targets; fixed‑dose regimen recommended with trough monitoring, modelled using…

CertaraJanuary 30, 2024

Publication

The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model

Find out how PK‑PD modelling shows delayed lipid‑lowering effects driven by key flavonoids in Wendan…

CertaraJanuary 23, 2024

Publication

Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old

Explore how weight and age drive azithromycin PK variability; PopPK modelling supports personalized dosing using…

CertaraJanuary 20, 2024

On-Demand Webinar

Streamlining Your NCA Workflow

PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…

CertaraJanuary 18, 2024

Certara Products – Phoenix

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud

Phoenix UGM 2024: A day of innovation and collaboration

Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults

Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors

What is new in Phoenix 8.5?

Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu

Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis

The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model

Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old

Streamlining Your NCA Workflow

Newsletter sign up

Quick links

Solutions

Contact